Results showed single-administration GLP-1 pancreatic gene therapy candidate reduced liver weight by 42% (p
Fractyl Health Presents Compelling Preclinical Data from Single-Administration GLP-1 Pancreatic Gene Therapy Rejuva® at Digestive Disease Week 2024
Watch Fractyl Health's latest callFractyl Health (NASDAQ:GUTS) Q2 2026 Earnings Call · Replay · Aug 10Read the transcript of Fractyl Health (NASDAQ:GUTS) Q2 2026 Earnings CallStory so far
Earlier from Fractyl Health
- Fractyl Health Presents Clinical Update on Revita® German Real-World Registry for Patients With Advanced Type 2 Diabetes (T2D)
- Fractyl Health Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 Conference and the German Diabetes Association (DDG) Annual Meeting
- Fractyl Health Expands Leadership with Appointment of Adrian Kimber as Chief Commercial Officer to Spearhead Anticipated Launch Preparation as the Company Conducts Two Pivotal Studies for Revita in Obesity and Type 2 Diabetes
- Fractyl Health Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
- Fractyl Health Receives FDA IDE Approval for the Revita® Remain-1 Pivotal Study of Weight Maintenance in Obesity after Discontinuation of GLP-1 Based Drugs
Later from Fractyl Health
- Fractyl Health to Present New Preclinical Obesity Data from Rejuva® Platform at the American Diabetes Association’s 84th Scientific Sessions
- Fractyl Health Presents New Preclinical Data on Sustained Weight Maintenance and Improved Body Composition from its Rejuva® Single-Administration GLP-1 Pancreatic Gene Therapy in President’s Select Oral Presentation at the American Diabetes Associatio...
- Fractyl Health Announces Advancement in Weight Maintenance Pipeline and Business Updates
- Fractyl Health Receives FDA Breakthrough Device Designation for Revita in Weight Maintenance for People with Obesity Who Discontinue GLP-1 Based Drugs
- Fractyl Health Announces Clinical Results from German Real-World Registry Showing Meaningful and Sustained Weight Loss for at Least One Year After a Single Revita® Endoscopic Procedure
Follow Fractyl Health into a list and get an email when it puts out news.
Follow Fractyl Health